BioXcel Therapeutics, Inc. BTAIQ
0.01 USD 0.00 (-16.67%)
Nov 12, 2026, 3:50 PM EST
0.008 Day range 0.0125
0.008 52-week range 2.25
- YTD
- -99.38%
- 1 year
- -99.42%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 642.00K | 2.27M | 1.38M | 375.00K | 0 | |
| 478.00K | 123.00K | 120.00K | 355.00K | 0 | |
| -50.46M | -67.25M | -171.78M | -159.65M | -106.94M | |
| -69.90M | -59.60M | -179.05M | -165.76M | -106.93M | |
| -5.73 | -23.51 | -98.33 | -95.00 | -65.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.76M | 29.85M | 65.22M | 193.72M | 232.97M | |
| 44.92M | 38.34M | 73.70M | 205.85M | 239.44M | |
| 140.38M | 131.44M | 130.21M | 129.08M | 17.77M | |
| 109.59M | 102.57M | 101.04M | 93.84M | 1.10M | |
| -95.46M | -93.10M | -56.51M | 76.78M | 221.67M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -57.62M | -72.03M | -155.01M | -135.34M | -82.15M | |
| 56.52M | 36.66M | 26.52M | 96.24M | 102.45M | |
| -1.10M | -35.37M | -128.50M | -39.24M | 19.85M |